Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma

被引:19
|
作者
Hu, Daixing [1 ]
Lin, Huapeng [2 ]
Zeng, Xuan [3 ]
Wang, Tielin [4 ]
Deng, Jie [5 ]
Su, Xinliang [1 ]
机构
[1] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Intens Care Unit, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China
[3] Chongqing Med Univ, Dept Oncol, Affiliated Hosp 2, Chongqing 400010, Peoples R China
[4] Third Peoples Hosp Chengdu, Dept Breast & Thyroid Surg, Chengdu 610031, Sichuan, Peoples R China
[5] Sichuan Univ, Dept Rehabil, West China Hosp, Med Ctr, Chengdu 610041, Sichuan, Peoples R China
关键词
NODAL METASTASIS; CANCER; COMPARTMENT; MANAGEMENT;
D O I
10.1007/s00268-019-05332-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Cervical lymph node metastasis is a prognostic factor of papillary thyroid carcinoma (PTC). Skip metastasis (central lymph node negative and lateral lymph node positive) of PTC is not uncommon. This study aimed to retrospectively investigate the risk factors for skip metastasis in PTC and develop a prediction model for skip metastasis. Methods A total of 745 PTC patients underwent total thyroidectomy and central plus lateral lymph node dissection at the First Affiliated Hospital of Chongqing Medical University from January 2012 to December 2017. Clinicopathological characteristics were collected and analyzed. Univariate and multivariate analyses were performed to detect the risk factors for skip metastasis. A prediction model was established based on the results of multivariate analyses. Results The skip metastasis rate was 9.7% (72/745). Age > 55 years (OR 2.63, 95% CI 1.34-5.04, p = 0.004), tumor located in the upper portion (OR 4.15, 95% CI 2.30-7.63, p = 0.001), and unilaterality (OR 2.76, 95% CI 1.14-8.23, p = 0.040) were independent risk factors for skip metastasis. Clinically lymph node-negative (cN0) patients with tumor in the upper portion (24.6%, 43/175) had higher possibility of skip metastasis than those of clinically lateral lymph node-positive (cN1b) patients (5.9%, 10/169) (p = 0.001). The area under the receiver operating characteristic curve of prediction model was 0.734 and 0.740 in derivation group and validation group, respectively. However, skip metastasis was not associated with tumor-free survival rate of PTC patients (p = 0.274). Conclusion Age > 55 years, tumor located in the upper portion, and unilaterality may increase the risk of skip metastasis. We developed the first prediction model for skip metastasis based on clinicopathological parameters in PTC patients.
引用
收藏
页码:1498 / 1505
页数:8
相关论文
共 50 条
  • [21] Predictive Factors for Skip Lymph Node Metastasis and Their Implication on Recurrence in Papillary Thyroid Carcinoma
    Ryu, Young-Jae
    Kwon, Seong-Young
    Lim, Soo-Young
    Na, Yong-Min
    Park, Min-Ho
    BIOMEDICINES, 2022, 10 (01)
  • [22] Analysis of Risk Factors and Risk Prediction for Cervical Lymph Node Metastasis in Thyroid Papillary Carcinoma
    Tian, Dandan
    Li, Xiaoqin
    Jia, Zhongzhi
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1571 - 1585
  • [23] Risk factors of suprasternal lymph node metastasis in papillary thyroid carcinoma with clinical lateral cervical lymph node metastasis
    Kwon, Hyun-Keun
    Cheon, Yong-Il
    Shin, Sung-Chan
    Sung, Eui-Suk
    Lee, Jin-Choon
    Kim, In Ju
    Lee, Byung-Joo
    GLAND SURGERY, 2021, 10 (02) : 512 - 520
  • [24] Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma
    Shan Jin
    Wuyuntu Bao
    Yun-Tian Yang
    Tala Bai
    Yinbao Bai
    Scientific Reports, 8
  • [25] Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
    Daixing Hu
    Jing Zhou
    Wei He
    Jie Peng
    Yijia Cao
    Haoyu Ren
    Yu Mao
    Yi Dou
    Wei Xiong
    Qi Xiao
    Xinliang Su
    World Journal of Surgical Oncology, 16
  • [26] Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
    Hu, Daixing
    Zhou, Jing
    He, Wei
    Peng, Jie
    Cao, Yijia
    Ren, Haoyu
    Mao, Yu
    Dou, Yi
    Xiong, Wei
    Xiao, Qi
    Su, Xinliang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [27] Risk factors for the lateral cervical lymph node metastasis of papillary thyroid carcinoma: A clinical study
    Masui, Takashi
    Adachi, Shiori
    Uemura, Hirokazu
    Kimura, Takahiro
    Kitahara, Tadashi
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 18 (04)
  • [28] Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma
    Jin, Shan
    Bao, Wuyuntu
    Yang, Yun-Tian
    Bai, Tala
    Bai, Yinbao
    SCIENTIFIC REPORTS, 2018, 8
  • [29] Risk factor analysis and prediction model for papillary thyroid carcinoma with lymph node metastasis
    Lu, Juerong
    Liao, Jintang
    Chen, Yunhao
    Li, Jie
    Huang, Xinyue
    Zhang, Huajun
    Zhang, Bo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [30] Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma
    Yoon, Jee Hee
    Park, Ji Yong
    Hong, A. Ram
    Kim, Hee Kyung
    Kang, Ho-Cheol
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15